Join the Tralokinumab group to help and get support from people like you.
Tralokinumab Support Group
Summary
Our support group for Tralokinumab has 1 questions and 3 members. Updated 7 May 2023.
Latest questions
Further information
Related condition support groups
Contact Dermatitis, Atopic Dermatitis
Tralokinumab Patient information at Drugs.com
Latest news
LEO Pharma Inc. Announces U.S. FDA Approval of Adbry (tralokinumab-ldrm) for the Treatment of Moderate-to-Severe Atopic Dermatitis in Pediatric Patients Aged 12-17 Years
Adbry is the first treatment for pediatric patients with moderate-to-severe atopic dermatitis specifically targeting…